Corticosteroids influence the mortality and morbidity of acute critical illness
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Introduction: Use of corticosteroids for adrenal supplementation and attenuation of the inflammatory and immune response is widespread in acute critical illness. The study hypothesis was that exposure to corticosteroids influences the mortality and morbidity in acute critical illness. Methods: This case–control retrospective study was performed in a single multidisciplinary intensive care unit at a tertiary care institution and consisted of 10,285 critically ill patients admitted between 1 January 1999 and 31 December 2004. Demographics, comorbidities, acute illness characteristics including severity measured by Sequential Organ Failure Assessment, concurrent medications, therapeutic interventions and incidence of infections were obtained from electronic medical records, were examined with multiple regression analysis and were adjusted for propensity of corticosteroid exposure. The primary outcome was hospital death, and the secondary outcome was transfer to a care facility at hospital discharge. Results: Corticosteroid exposure in 2,632 (26%) patients was characterized by younger age, more females, higher Charlson comorbidity and maximal daily Sequential Organ Failure Assessment scores compared with control patients. Corticosteroids potentiated metabolic and neuromuscular sequels of critical illness with increased requirements for diuretics, insulin, protracted weaning from mechanical ventilation, need for tracheostomy and discharge to a care facility. Early exposure to corticosteroids predisposed to recurrent and late onset of polymicrobial and fungal hospital-acquired infections. Corticosteroids increased the risk for death or disability after adjustments for comorbidities and acute illness characteristics. Conclusion: Corticosteroids increased the risk for death or disability in critical illness. Hospital-acquired infections and metabolic and neuromuscular sequels of critical illness were exacerbated by corticosteroids. Careful appraisal of the indications for use of corticosteroids is necessary to balance the benefits and risks from exposure in acute critical illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“Corticosteroids are used therapeutically for relative adrenal insufficiency as well as for the attenuation of the inflammatory and immune response in the critically ill [1].”
BackgroundOne-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
Herridge, M. S., Cheung, A. M., Tansey, C. M., Matte-Martyn, A., Diaz-Granados, N., Al-Saidi, F., Cooper, A. B., Guest, C. B., Mazer, C. D., Mehta, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022450 · Cited by 2,334 · cited 2×
“Global and flaccid muscle weakness affecting the limb musculature, truncal musculature and respiratory musculature related to necrotizing myopathy have been reported with corticosteroid use in critical illness [31-34].”
BackgroundRomano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Annane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000 · cited 1×
“6°C, white cell count >11,000 cells/mm3 or <4,000 cells/mm3, immature neutrophils (bands) >10%, respiratory rate >20/minute, PaCO2 <35 mmHg or requirement for mechanical ventilation, and heart rate >90/minute [22].”
Background
Cited by
Moving towards personalized treatments of immune-related adverse events
Esfahani, K., Elkrief, A., Calabrese, C., Lapointe, R., Hudson, M., Routy, B., Miller, W. H., & Calabrese, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0352-8 · Cited by 351
Adrenal insufficiency in critical illness
Cooper, M. S., & Stewart, P. M. (2007) · Journal of Intensive Care Medicine · doi:10.1177/0885066607307832 · Cited by 97
“This improvement in hemodynamics with these lower dose regimens has also been seen in several observational studies [23,86,99,100]; however, other studies have failed to show an association with improved hemodynamics or mortality [101], and others have suggested an association of a poorer outcome with corticosteroid u…”
ResultLoisa, P., Parviainen, I., Tenhunen, J., Hovilehto, S., & Ruokonen, E. (2007) · Critical Care · doi:10.1186/cc5696 · Cited by 95
“It is possible that corticosteroid treatment may induce hyperglycemia and that the frequency of insulin use may increase with corticosteroid exposure [7].”
BackgroundSteroid myopathy in patients with chronic respiratory diseases
Levin, O. S., Polunina, A. G., Demyanova, M. A., & Isaev, F. V. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.12.023 · Cited by 35
“Overall, our study supports the view that side effects of corticosteroids are common and damaging, and these highly active drugs should be used cautiously [27].”
Background
Metadata
- Authors
- Rady, M. Y., Johnson, D. J., Patel, B., Larson, J., & Helmers, R.
- Venue
- Critical Care
- Published
- 2006-07-17
- Volume
- 10
- Issue
- 4
- Pages
- R101-R101
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W1837154146
- Cited by
- 48
- References
- 4
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Corticosteroids influence the mortality and morbidity of acute critical illness. https://app.cochat.ai/papers/10.1186/cc4971
- The paper
- Rady, M. Y., Johnson, D. J., Patel, B., Larson, J., & Helmers, R. (2006). Corticosteroids influence the mortality and morbidity of acute critical illness. Critical Care. https://doi.org/10.1186/cc4971
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.